Market Signal Briefing

Amsterdam, 22 October 2025 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces

Staying the course while navigating a challenging quarter

Revenue €8,712 million for the quarter, €25,636 million year to date Net revenue (beia) organically down 0.3% for the quarter, up 1.3% year to date Beer volume organically down 4.3% for the quarter, down 2.3% year to date Premium beer volume organically down 2.2% for the quarter, up 0.4% year to date Heineken® volume down 0.6% for the quarter, up 2.7% year to date 2025 organic operating profit (beia) growth anticipated to be towards the lower end of the 4% to 8% guidance
Dolf van den Brink, Chairman of the Executive Board / CEO, commented:
"Macroeconomic volatility persisted as anticipated and became more pronounced in the third quarter, creating a challenging environment, resulting in a mixed performance. We expect consumer confidence and demand to recover when conditions normalise. 

Our advantaged geographical footprint helped us adapt, amongst others with solid beer volume growth in Southern Africa, gains across the portfolio in Vietnam, and continued strong growth for Heineken® and Amstel in China, partially offsetting some of the weakness in Europe and the Americas. We are also excited about the announced FIFCO transaction in Central America, which will further strengthen our growth footprint and be earnings accretive.

Staying the course on our EverGreen strategy, our portfolio continues to evolve positively, with market share gains in a substantial majority of our markets, and Heineken® and premium volume growing year-to-date. Furthermore, we are future-proofing the business by accelerating digital investments and reshaping our organisation.

Taking into account the challenging quarter, we remain confident in delivering €0.5 billion gross savings for 2025, and anticipate our full year organic operating profit (beia) growth to be towards the lower end of our 4% to 8% guidance."

Enquiries Media   Investors     Christiaan Prins   Tristan van Strien     Global Communications Director   Investor Relations Director     Marlie Paauw   Lennart Scholtus / Chris Steyn     Global Media Lead   Investor Relations Manager / Senior Analyst     E-mail: [email protected]   E-mail: [email protected]     Tel: +31-20-5239355   Tel: +31-20-5239590     HEINEKEN will host an analyst and investor conference call with Harold van den Broek, Chief Financial Officer, in relation to its Third Quarter 2025 Trading Update today at 09:30 CET/08:30 GMT. The call will be audio cast live via the company’s website: www.theheinekencompany.com. An audio replay service will also be made available after the conference call at the above web address. Analysts and investors can dial-in using the following telephone numbers:
United Kingdom (Local): 020 3936 2999
Netherlands (Local): 085 888 7233
USA (Local):  646 664 1960

For the full list of dial in numbers, please refer to the following link: Global Dial-In Numbers

Participation password for all countries: 776757.

On Thursday 23 October 2025 HEINEKEN is hosting a Capital Markets Event. To join virtually please refer to the following link: HEINEKEN CME 2025

HEINEKEN NV Q3 2025 Trading Update

Summarylululemon is beginning to show signs of maturing growth in the America's and tariff impacts will be an additional headwind, but the 60% pullback has gone too far.lululemon remains an aspirational brand with strong consumer appeal and solid growth in international markets.Current valuation now looks attractive at 11.4x TTM P/E as it reflects a more reasonable pricing of future growth. jetcityimage/iStock Editorial via Getty Images

lululemon (NASDAQ:LULU)(NEOE:LULU:CA) has been an aspirational brand for well over a decade now, and while the company is showing early signs of maturing growth, the valuation has become a lot more appealing with

Analyst’s Disclosure:I/we have a beneficial long position in the shares of LULU either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I am long Lululemon with an average cost base of $169.06 and have owned Levi Strauss at times in the past. Disclaimer: While the information and data presented in my articles are obtained from company documents and/or sources believed to be reliable, they have not been independently verified. The material is intended only as general information for your convenience, and should not in any way be construed as investment advice. I advise readers to conduct their own independent research to build their own independent opinions and/or consult a qualified investment advisor before making any investment decisions. I explicitly disclaim any liability that may arise from investment decisions you make based on my articles.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

By Reuters

October 22, 20255:14 AM UTCUpdated ago

A person walks past the UniCredit bank branch in Rome, Italy, November 25, 2024. REUTERS/Yara Nardi Purchase Licensing Rights, opens new tab

MILAN, Oct 22 (Reuters) - UniCredit

(CRDI.MI), opens new tab on Wednesday confirmed its profit outlook for the year after reporting a higher-than-expected quarterly income thanks to trading gains.

Italy's second-biggest bank said net profit in the July-September period was 2.6 billion euros ($3.03 billion), above a 2.4 billion euro company-provided analyst consensus forecast.

Sign up here.

It confirmed a profit goal for the year of 10.5 billion euros, which is expected to rise above 11 billion in 2027.

($1 = 0.8575 euros)

Reporting by Valentina Za, editing by Giulia Segreti

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in RIO over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

“Gold had several attempts to break higher last week, but resistance near the upper range held firm,” said David Morrison, senior market analyst at Trade Nation. “This correction may represent a healthy reset after an overextended run.”

Central Banks Still Accumulating Gold
Despite the short-term setback, demand from institutional investors and central banks remains robust. According to the World Gold Council, global central banks purchased nearly 1,100 metric tons of gold in the first three quarters of the year, one of the highest totals on record.

Exchange-traded funds have also seen consistent inflows, reflecting investor appetite for diversification amid fiscal uncertainty.

Analysts note that macroeconomic fundamentals continue to favor the yellow metal. “You still have elevated inflation, low real yields, and geopolitical risk—all supportive factors for gold,” said Tom Essaye, founder of Sevens Report Research.

Wall Street Maintains Bullish Long-Term Outlook
Major banks remain optimistic on gold’s trajectory. Goldman Sachs forecasts gold reaching $4,900 per ounce by the end of next year, while Bank of America maintains a long position with a $6,000 per ounce target by mid-2026. JPMorgan projects similar highs by 2029, citing persistent global debt and currency debasement concerns.

Silver, meanwhile, continues to benefit from strong industrial demand, particularly from the solar energy and electronics sectors, providing a partial cushion against market volatility.

Robert Barrie
Founder, Executive Chairman & CEO

Hello, and welcome to the Freelancer Limited Third Quarter of 2025 Business Update. My name is Matt Barrie. I'm the Chief Executive and Chairman of Freelancer Limited. Today with me in the room, I have our Chief Financial Officer, Neil Katz, to my left. I have Andrew Bateman, who is VP of Products; as well as Adam Byrnes, VP of Products, both strategy and product management side of things. I have Mas from Loadshift and from the Field Services division of Freelancer and August Piao from Escrow.com.

And as always, at the end of the Q&A, you may address your questions to any of the executives in the room or you may follow up if you like to do one-on-one by e-mailing [email protected].

In the third quarter, which was the Northern Hemisphere summer quarter, so usually, it is a little bit quiet. The group GMV was down 22.5%. That's primarily due to a single USD 50 million transaction that we lapped from the third quarter of 2024 from escrow. The Freelancer GMV was up a little bit, 4%, almost $34.1 million. The Escrow GMV lapped obviously that large transaction spike. And I will say, actually, we're looking at a reasonably large transaction happening in the next quarter. So you may see a reversal of that in Q4.

Group revenue was basically flat at $13.8 million. The Freelancer revenue was at $10.1 million, was down 2.2% and the escrow revenue was up 2.9% at $3.2 million, even though we lapped that single transaction spike. The group continued to achieve

KKR Co-CEO Joseph Bae says global investors with heavy US exposure are steadily shifting more capital to Asia as the dollar loses steam and the region's fundamentals shine. Speaking exclusively with Bloomberg's Haslinda Amin, Bae also talks about the firm's strategies in Japan, India and China.

Malaysia modernizes mobile command and control, securing voice and messaging for inter-agency coordination with BlackBerry AtHoc and BlackBerry SecuSUITE KUALA LUMPUR, MY / ACCESS Newswire / October 21, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) today announced that Malaysia has deployed BlackBerry® AtHoc® and BlackBerry® SecuSUITE® to secure communications and protect people during the ASEAN Summit events in 2025, including the 46th ASEAN Summit held in May, and the 47th ASEAN Summit taking place in Kuala Lumpur from October 26 to 28. Photo Credit: Ministry of Foreign Affairs, Malaysia.

CNBC's MacKenzie Sigalos reports on OpenAI's new browser launch — a generative AI-powered alternative to Chrome and Comet that's designed to surf the web, complete tasks, and follow users across every page.

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced the pricing of $1.0 billion aggregate principal amount of convertible senior notes due 2036 (the “Notes”) in a private offering (the “Notes Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The size of the offering has been increased from the previously announced $850.0 million principal amount of Notes. The sale of the Notes to the initial purchasers is expected to settle on October 24, 2025, subject to customary closing conditions.

The Notes have an initial conversion price of approximately $96.30 per share of AST SpaceMobile’s Class A common stock, which represents a premium of approximately 22.5% to the last reported sale price of AST SpaceMobile’s Class A common stock on October 21, 2025.

Option to Purchase Additional Notes:

AST SpaceMobile also granted the initial purchasers of the Notes in the Notes Offering an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $150.0 million aggregate principal amount of Notes.

Use of Proceeds:

AST SpaceMobile estimates that the net proceeds from the Notes Offering will be approximately $981.9 million (or approximately $1,129.2 million if the initial purchasers’ option to purchase additional Notes is exercised in full), after deducting the initial purchasers’ discounts and commissions and estimated offering expenses payable by AST SpaceMobile. AST SpaceMobile intends to use the net proceeds from the Notes Offering for general corporate purposes, including without limitation funding the deployment of AST SpaceMobile’s worldwide constellation of satellites in anticipation of adding incremental strategic markets for AST SpaceMobile’s SpaceMobile Service.

Additional Details of the Notes:

The Notes will be senior, unsecured obligations of AST SpaceMobile. The Notes will accrue interest at an annual rate of 2.00%, payable semiannually in arrears on January 15 and July 15 of each year, beginning on July 15, 2026. The Notes will mature on January 15, 2036, unless earlier converted, redeemed or repurchased.

Prior to the close of business on the business day immediately preceding October 15, 2035, noteholders will have the right to convert their Notes only upon the satisfaction of specified conditions and during certain periods. On or after October 15, 2035 and until the close of business on the second scheduled trading day immediately preceding January 15, 2036, noteholders may convert their Notes at any time regardless of these conditions. The initial conversion rate will be 10.3845 shares of AST SpaceMobile’s Class A common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $96.30 per share of AST SpaceMobile’s Class A common stock, which represents a premium of approximately 22.5% over the last reported sale price of $78.61 per share of AST SpaceMobile’s Class A common stock on the Nasdaq Global Select Market on October 21, 2025), subject to adjustment in certain circumstances. AST SpaceMobile will settle conversions of Notes by paying or delivering, as the case may be, cash, shares of AST SpaceMobile’s Class A common stock, or a combination thereof, at AST SpaceMobile’s election.

The Notes will not be redeemable at AST SpaceMobile’s option prior to January 22, 2029. AST SpaceMobile may, at its option, redeem all or any portion of the Notes for cash on or after January 22, 2029, but only if the last reported sale price per share of AST SpaceMobile’s Class A common stock equals or exceeds 130% of the conversion price for a specified period of time and certain liquidity conditions have been satisfied. The redemption price will be equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

Noteholders will have the right, subject to certain conditions and exceptions described in the indenture governing the Notes (the “indenture”), to require AST SpaceMobile to repurchase for cash all or a portion of their Notes upon the occurrence of a fundamental change (as defined in the indenture) at a purchase price of 100% of their principal amount plus accrued and unpaid interest, if any, to, but excluding, the relevant repurchase date. In addition, following certain corporate events that occur prior to January 15, 2036 or if AST SpaceMobile delivers a notice of redemption, AST SpaceMobile will, in certain circumstances, increase the conversion rate for a noteholder who elects to convert its Notes in connection with such corporate events or convert its Notes in connection with such notice of redemption, as the case may be.

The Notes are only being offered and will only be sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act by means of a private offering memorandum. Neither the Notes nor the shares of AST SpaceMobile’s Class A common stock potentially issuable upon conversion of the Notes, if any, have been, or will be, registered under the Securities Act or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States, except pursuant to an applicable exemption from, or in a transaction not subject to, such registration requirements.

This announcement is neither an offer to sell nor a solicitation of an offer to buy any of the Notes or any shares of AST SpaceMobile’s Class A common stock potentially issuable upon conversion of the Notes and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale is unlawful.

Registered Direct Offering/Existing Convertible Notes Repurchases:

In a separate press release, AST SpaceMobile also announced today the pricing of its previously announced registered direct offering of approximately 2.0 million shares of its Class A common stock, at a price of $78.61 per share. The issuance and sale of the shares of AST SpaceMobile’s Class A common stock are scheduled to settle on October 29, 2025, subject to customary closing conditions.

AST SpaceMobile intends to use the net proceeds from the registered direct offering, together with cash on hand, to repurchase $50.0 million aggregate principal amount of its existing 4.25% convertible senior notes due 2032 (the “Existing Notes”) in the existing convertible notes repurchases described below.

Concurrently with the pricing of the Notes Offering, AST SpaceMobile entered into separate, privately negotiated transactions with a limited number of holders of its Existing Notes to repurchase $50.0 million principal amount of the Existing Notes for cash (the “existing convertible notes repurchases”). The existing convertible notes repurchases will be subject to closing conditions that may not be consummated. In addition, following completion of the Notes Offering, AST SpaceMobile may repurchase additional existing notes.

In connection with the existing convertible notes repurchases, certain holders of the Existing Notes that participate in such repurchases may purchase or sell shares of AST SpaceMobile’s Class A common stock in the open market or enter into or unwind various derivative transactions with respect to AST SpaceMobile’s Class A common stock to unwind any hedge positions they may have with respect to the Existing Notes or to hedge or unwind their exposure in connection with such repurchases. The amount of AST SpaceMobile’s Class A common stock to be sold or purchased by such holders or the notional number of shares of AST SpaceMobile’s Class A common stock underlying such derivative transactions may be substantial in relation to the historic average daily trading volume of AST SpaceMobile’s Class A common stock. These activities may adversely affect the trading price of AST SpaceMobile’s Class A common stock and the trading price of the Notes and Existing Notes. AST SpaceMobile cannot predict the magnitude of such market activities or the overall effect they will have on the price of the Notes, the Existing Notes or AST SpaceMobile’s Class A common stock.

The completion of the Notes Offering is not contingent on the completion of the registered direct offering and the existing convertible notes repurchases and the completion of the registered direct offering and the existing convertible notes repurchases is not contingent on the completion of the Notes Offering. The registered direct offering and the existing convertible notes repurchases are cross-conditional. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any shares of AST SpaceMobile’s Class A common stock in the registered direct offering. This press release does not constitute an offer to buy, or a solicitation of any offer to sell, any Existing Notes.

About AST SpaceMobile

AST SpaceMobile is building the first and only global cellular broadband network in space to operate directly with standard, unmodified mobile devices and designed for both commercial and government applications. Our engineers and space scientists are on a mission to eliminate the connectivity gaps faced by today’s five billion mobile subscribers and finally bring broadband to the billions who remain unconnected.

Forward-Looking Statements

This communication contains “forward-looking statements” that are not historical facts, including statements concerning the completion of the Notes Offering, the granting of a 13-day option to purchase additional Notes, the expected use of the net proceeds from the Notes Offering, and the concurrent registered direct offering of AST SpaceMobile’s Class A common stock and separate repurchase of a portion of its Existing Notes. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “anticipates,” “expects,” “intends,” “may,” “will,” “potential,” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Such risks include, but are not limited to, whether AST SpaceMobile will consummate the Notes Offering, the registered direct offering and the existing convertible notes repurchase, prevailing market conditions, the anticipated principal amount of the Notes, which could differ based upon the exercise of the initial purchasers’ option to purchase additional Notes, the anticipated use of the net proceeds from the Notes Offering, which could change as a result of market conditions or for other reasons, whether AST SpaceMobile will consummate the registered direct offering or repurchase of Existing Notes, the effects of entering into these transactions, and the impact of general economic, industry or political conditions in the United States or internationally.

AST SpaceMobile cautions that the foregoing list of factors is not exclusive. AST SpaceMobile cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors in AST SpaceMobile’s Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 3, 2025, its Form 10-Q for the fiscal quarter ended March 31, 2025 filed with the SEC on May 12, 2025, its Form 10-Q for the fiscal quarter ended June 30, 2025 filed with the SEC on August 11, 2025, as amended on September 12, 2025, and the future reports that it may file from time to time with the SEC. AST SpaceMobile’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, AST SpaceMobile disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

More News From AST SpaceMobile, Inc.

October 21, 2025 23:12 ET

 | Source:

RAPT Therapeutics, Inc.

SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced the pricing of an underwritten public offering of 8,333,334 shares of its common stock at a price to the public of $30.00 per share. In addition, RAPT has granted the underwriters a 30-day option to purchase up to an additional 1,250,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered by RAPT. The gross proceeds from the offering to RAPT are expected to be approximately $250.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about October 23, 2025, subject to customary closing conditions.

Leerink Partners, TD Cowen, Guggenheim Securities, Wells Fargo Securities and LifeSci Capital are acting as joint bookrunning managers for the offering. H.C. Wainwright & Co. and Clear Street are acting as lead managers for the offering.

The offering is being made pursuant to a shelf registration statement, including a base prospectus, filed by RAPT with the Securities and Exchange Commission (the “SEC”), which was declared effective by the SEC on August 17, 2023. The offering may be made only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. A final prospectus supplement and accompanying prospectus will be filed with the SEC. When available, electronic copies of the final prospectus supplement and the accompanying prospectus may also be obtained from: Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at 1-800-808-7525 ex. 6132 or by email at [email protected]; TD Securities (USA) LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected]; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, by telephone at (212) 518-9544, or by email at [email protected]; Wells Fargo Securities, LLC, Attention: Wells Fargo Securities, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, at 800-645-3751 (option #5) or email a request to [email protected]; or LifeSci Capital LLC at 1700 Broadway, 40th Floor, New York, New York 10019, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About RAPT Therapeutics, Inc.

RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to RAPT’s expectations regarding the offering, including expected gross proceeds and anticipated closing date, the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all. These statements are subject to significant risks and uncertainties and actual results could differ materially from those projected. RAPT cautions investors not to place undue reliance on the forward-looking statements contained in this release. These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions, the risk that the public offering will not be consummated on the terms or in the amounts contemplated or otherwise, and the satisfaction of customary closing conditions related to the public offering. Risks and uncertainties relating to RAPT and its business can be found in the “Risk Factors” section of RAPT’s Form 10-Q for the quarter ended June 30, 2025, filed with the SEC on August 7, 2025, and in the preliminary prospectus supplement related to the public offering filed with the SEC on October 21, 2025, and in the final prospectus supplement related to the public offering to be filed with the SEC. RAPT undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in RAPT’s expectations, except as required by law.

RAPT Investor Contact:
Sylvia Wheeler
[email protected]

RAPT Media Contact:
Aljanae Reynolds
[email protected]

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced the pricing of an underwritten public offering of shares of its common stock. Viridian is selling a total of 11,425,000 shares of common stock at a public offering price of $22.00 per share. In addition, Viridian has granted the underwriters a 30-day option to purchase an additional 1,713,750 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Viridian from the offering are expected to be approximately $251,350,000, before deducting underwriting discounts and commissions and offering expenses payable by Viridian and assuming no exercise of the underwriters’ option to purchase additional shares.

All of the shares to be sold in the underwritten public offering are being offered by Viridian. The offering is expected to close on or about October 23, 2025, subject to customary closing conditions.

Viridian intends to use the proceeds from the proposed underwritten public offering of its shares of common stock, together with its cash, cash equivalents and short-term investments, to fund the company’s commercial launch activities related to veligrotug and VRDN-003 and research and development activities, as well as for working capital and general corporate purposes.

Jefferies, Leerink Partners, Evercore ISI and Stifel are acting as joint book-running managers for the offering. Wedbush PacGrow is acting as co-manager for this offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission (SEC) and became effective on September 5, 2025. A final prospectus supplement and accompanying base prospectus relating to and describing the terms of the offering will be filed with the SEC. The securities described above have not been qualified under any state blue sky laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. The offering will only be made by means of a prospectus, copies of which may be obtained at the SEC’s website at www.sec.gov, or by request to Jefferies LLC (Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022; telephone: 877-821-7388; email: [email protected]); Leerink Partners LLC, Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105, or by email at [email protected]; Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, New York 10055, by telephone at (888) 474-0200 or by email at [email protected]; or Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, telephone: (415) 364‐2720 or by emailing [email protected].

About Viridian Therapeutics, Inc.

Viridian is a biopharmaceutical company focused on discovering, developing and commercializing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.

Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting a pivotal program for veligrotug (VRDN-001), including two global phase 3 clinical trials (THRIVE and THRIVE-2), to evaluate its efficacy and safety in patients with active and chronic TED. Both THRIVE and THRIVE-2 reported positive topline data, meeting all the primary and secondary endpoints of each study. Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2, to evaluate the efficacy and safety of VRDN-003 in patients with active and chronic TED.

In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words such as, but not limited to, “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or other similar terms or expressions that concern the company’s expectations, plans and intentions. Forward-looking statements include, without limitation, statements regarding: the underwritten public offering; the company’s expectations with respect to the use of the net proceeds from the underwritten public offering; the company’s plans regarding commercial launch activities related to veligrotug and VRDN-003 and research and development activities; the impact of a prolonged United States federal government shutdown; the company’s belief that VRDN-003 may be a best-in-class subcutaneous therapy for the treatment of TED; and the potential for the company’s novel portfolio of FcRn inhibitors to be developed in multiple autoimmune diseases. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on the company’s current beliefs, expectations and assumptions. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to: the satisfaction of customary closing conditions related to the underwritten public offering; and other risks and uncertainties identified in the company’s filings with the SEC, including those risks set forth under the caption “Risk Factors” in the company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the SEC on August 6, 2025, and other subsequent disclosure documents filed with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the company, nor its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the company’s views as of any date subsequent to the date hereof.

More News From Viridian Therapeutics, Inc.

SummaryRed Cat Holdings offers a compelling entry point after a pullback, with shares now in the low $12 range ahead of 3Q25 earnings.RCAT is driving growth through AI integration in its Black Widow drones and a transformative partnership with AeroVironment for modular, marsupial drone systems.A recent $172.5 million public offering and strong cash reserves position RCAT well for scaling production and pursuing new defense contracts.Despite high valuation multiples, RCAT's expanding defense partnerships, AI capabilities, and anticipated contract wins support a bullish outlook for long-term investors.shcherbak volodymyr/iStock via Getty Images

Thesis Red Cat Holdings (NASDAQ:RCAT) shares have seen quite the pullback after a strong run-up to a 52-week high of $16.70. Shares can now be acquired in the low $12 range, which opens up a nice buying opportunity

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Analyst’s Disclosure:I/we have a beneficial long position in the shares of ASIX, LYB either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. It may be structured as such, but it is not financial advice. Investors are required and expected to do their own due diligence and research prior to any investment.
Short-term trading, options trading/investment, and futures trading are potentially extremely risky investment styles. They generally are not appropriate for someone with limited capital, limited investment experience, or a lack of understanding of the necessary risk tolerance involved. I own the European/Scandinavian tickers (not the ADRs) of all European/Scandinavian companies listed in my articles.
I own the Canadian tickers of all Canadian stocks I write about. Please note that investing in European/Non-US stocks comes with withholding tax risks specific to the company's domicile as well as your personal situation. Investors should always consult a tax professional as to the overall impact of dividend withholding taxes and ways to mitigate these.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NEW YORK and NEW ORLEANS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against WPP plc (NYSE: WPP), if they purchased or otherwise acquired the Company’s shares between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased shares of WPP and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-wpp/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by December 8, 2025.

About the Lawsuit

WPP and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On July 9, 2025, the Company published a trading update for the first half of 2025, disclosing that it had allegedly “seen a deterioration in performance as Q2 has progressed” due to both “continued macro uncertainty weighing on client spend and weaker net new business than originally anticipated,” as well as “some distraction to the business” as a result of the continued restructuring of WPP Media a.k.a. GroupM. The Company further disclosed that its CEO “will retire from the Board and as CEO on 31 December 2025.”

On this news, the price of WPP’s shares fell from a closing price of $35.82 per share on July 8, 2025 to $29.34 per share on July 9, 2025, a decline of about 18.1% in the span of just a single day.

The case is Marty v. WPP plc, 25-cv-08365.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Netflix's business leaders and investors probably aren't enjoying a soda pop after the release of its third-quarter results. While the company's revenue met expectations — though not beating them as it did the first and second quarters — earnings were taken down by a tax dispute with Brazilian authorities. Shares of Netflix fell around 6% in extended trading Tuesday stateside.

But it doesn't look like any other media company will dethrone Netflix as the king of streaming in the near term. Warner Bros. Discovery said Tuesday it's open to a sale — and Netflix is reportedly an interested buyer — even as Warner Bros. is going ahead with its split into two companies in the meantime. Elsewhere, Comcast's NBCUniversal is currently spinning off its cable networks, which includes CNBC. Those moves suggest that legacy media is still finding its footing amid the era of streaming inaugurated by Netflix.

While there are many factors contributing to Netflix's golden status, its shows are likely the main protagonists. "KPop Demon Hunters," released in June, was a smash hit. It's now the company's most-watched film, hitting 325 million views and surely played a huge role in Netflix's best ad sales quarter ever in the third quarter. Even as the streaming giant's earnings stumbled during that period, Netflix is still showing other media companies how it's done.

— CNBC's Sarah Whitten contributed to this report.

What you need to know todayAnd finally...Gold is getting knocked on Tuesday – it's still the hottest trade of the year

Precious metals have gained in 2025 thanks to concerns around global trade, expectations of Federal Reserve rate cuts and a drop in the U.S. dollar. But the size of those returns is unusual for gold and silver, especially when the stock market is doing well. 

Investors are seeing them as a scarce asset as the "currency debasement" trade gains momentum on Wall Street. This trade refers to investors hedging against government borrowing and money printing, lessening the U.S. dollar's value by moving into gold and other assets.

— Sean Conlon

Disclosure: Comcast is the parent company of NBCUniversal, which owns CNBC. Versant would become the new parent company of CNBC upon Comcast's planned spinoff of Versant.

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fortinet, Inc. (NASDAQ: FTNT) between November 8, 2024 and August 6, 2025, both dates inclusive (the "Class Period"), of the important November 21, 2025 lead plaintiff deadline.

So what: If you purchased Fortinet common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Fortinet class action, go to https://rosenlegal.com/submit-form/?case_id=45210 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 21, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made materially false and misleading statements concerning the business impact and sustainability of a purportedly "record" round of FortiGate unit upgrades. Defendants represented that this "refresh cycle" was "by far the largest we've seen probably ever," would generate "around $400 million to $450 million in product revenue" in 2025 and 2026, and would create strong opportunities to cross-sell additional products and services. Defendants also represented that the refresh cycle would "gain momentum" in the second half of 2025 and beyond.

The lawsuit alleges these statements were materially false and misleading. In truth, defendants knew that the refresh cycle would never be as lucrative as they represented because it consisted of old products that were a "small percentage" of the Company's business. Moreover, defendants misrepresented and concealed that they did not have a clear picture of the true number of FortiGate firewalls that could be upgraded. And while telling investors that the refresh would gain momentum over the course of two years, Fortinet misrepresented and concealed that it had aggressively pushed through roughly half of the refresh in a period of just a few months, by the end of 2Q 2025. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Fortinet class action, go to https://rosenlegal.com/submit-form/?case_id=45210 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

U.S. Department of Energy Secretary Chris Wright attends a Reuters Next event in Manhattan, New York City, U.S., September 25, 2025.REUTERS/Carlos Barria Purchase Licensing Rights, opens new tab

CompaniesHOUSTON, Oct 21 (Reuters) - U.S. Secretary of Energy Chris Wright gave Venture Global

(VG.N), opens new tab final approval on Tuesday to export liquefied natural gas (LNG) from its CP2 plant, under construction in Louisiana, to countries that do not have a free trade agreement with the U.S.

The approval will allow Venture Global to export 28 million metric tons per annum (mtpa) or 3.96 billion cubic feet per day of U.S. natural gas to so called non-Free Trade Agreement (FTA) countries.

Sign up here.

"In less than ten months, President Trump's administration is redefining what it means to unleash American energy by approving record new LNG exports," said Kyle Haustveit, Assistant Secretary of the Office of Fossil Energy.

Venture Global is the second-largest U.S. exporter of LNG and when the CP2 plant is complete could leapfrog Cheniere Energy

(LNG.N), opens new tab and become the largest U.S. exporter of the super-chilled gas.

"We look forward to continue advancing the project safely and quickly to bring new LNG to the global market at a record pace beginning in 2027," Venture Global's CEO Mike Sabel said in a statement to Reuters.

Companies need permission to export LNG to non-FTA countries. The majority of buyers in Europe and Asia do not have free trade agreements with the U.S.

In 2024, the U.S. under former President Joe Biden paused issuing of non-FTA export permits to LNG developers so it could study the environmental and economic impact of more U.S. export of LNG.

The Trump administration reversed that decision.

The authorization follows the Department of Energy's conditional authorization to Venture Global in March and the Federal Energy Regulatory Commission's May approval to construct the plant.

Reporting by Curtis Williams in Houston; Editing by Christopher Cushing

Our Standards: The Thomson Reuters Trust Principles., opens new tab

October 21, 2025 9:45 PM EDT | Source: Ivanhoe Electric
Phoenix, Arizona--(Newsfile Corp. - October 21, 2025) - Ivanhoe Electric Inc. (NYSE American: IE) (TSX: IE) ("Ivanhoe Electric"), Executive Chairman, Robert Friedland and President and Chief Executive Officer, Taylor Melvin are pleased to announce the pricing of an underwritten public offering of 10,000,000 shares of Ivanhoe Electric's common stock at a public offering price of US$15.00 per share. The gross proceeds from the offering are expected to be approximately US$150 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Ivanhoe Electric. In addition, Ivanhoe Electric has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

The offering is expected to close on October 23, 2025, subject to customary closing conditions.

We intend to use the net proceeds from this offering to complete the remaining payments owed from the purchase of land at our Santa Cruz Copper Project in Arizona, to fund early development activities at the Santa Cruz Copper Project, to fund exploration activities at our current projects and joint ventures, and for other working capital and general corporate purposes.

BMO Capital Markets is acting as lead book-running manager of the offering. J.P. Morgan and National Bank of Canada Capital Markets are acting as book-running managers of the offering.

A registration statement on Form S-3 (No. 333-273195) relating to these securities has been filed with the U.S. Securities and Exchange Commission (the "SEC") and was automatically declared effective on July 10, 2023. The shares being offered in this offering are being offered by means of a prospectus supplement and accompanying prospectus relating to the offering that form a part of the registration statement. A preliminary prospectus supplement relating to the offering was filed with the SEC on October 21, 2025, and is available on the SEC's website at http://www.sec.gov. The final prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will also be available on the SEC's website. Before investing in the offering, you should read each prospectus supplement and the accompanying prospectus relating to the offering in their entirety as well as the other documents that Ivanhoe Electric has filed with the SEC that are incorporated by reference in the prospectus supplement and the accompanying prospectus. Copies of the final prospectus supplement, when available, and accompanying prospectus relating to the offering may be obtained from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 W 42nd Street, 32nd Floor, New York, NY 10036, email: [email protected].

A preliminary MJDS prospectus supplement relating to the offering was filed with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada (except Québec) (the "Canadian Regulators") on October 21, 2025 and is available under Ivanhoe Electric's SEDAR+ profile at www.sedarplus.ca. The final MJDS prospectus supplement relating to and describing the terms of the offering will be filed with the Canadian Regulators and copies of the final MJDS prospectus supplement, when available, and accompanying final base MJDS prospectus relating to the offering may be obtained from the underwriters at the addresses set out above and will be available under Ivanhoe Electric's profile on SEDAR+ at www.sedarplus.ca.

In seeking the approval of the Toronto Stock Exchange of the Offering, Ivanhoe Electric is relying on the exemption set forth in Section 602.1 of the TSX Company Manual available to "Eligible lnterlisted Issuers", since Ivanhoe Electric's common stock is listed on the NYSE American and had less than 25% of its overall trading volume occurring in Canada during the 12 months prior to launch of the Offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Ivanhoe Electric

We are a U.S. company that combines advanced mineral exploration technologies (Typhoon™ and Computational Geosciences Inc.) with electric metals exploration projects predominantly located in the United States, headlined by the Santa Cruz Copper Project in Arizona. Our mineral exploration efforts focus on copper as well as other metals, including nickel, vanadium, cobalt, platinum group elements, gold, and silver. We also operate a 50/50 joint venture with Saudi Arabian Mining Company Ma'aden to explore for minerals on ~48,500 km2 of underexplored Arabian Shield in the Kingdom of Saudi Arabia.

Contact Information

Mike Patterson
Vice President, Investor Relations and Business Development
Email: [email protected]
Phone 1-480-601-7878

Forward-Looking Statements

This press release contains statements that constitute "forward looking information" and "forward-looking statements" within the meaning of U.S. and Canadian securities laws. All statements other than statements of historical facts contained in this press release, including statements regarding the expected closing date and consummation of the offering and the use of proceeds from the offering are forward-looking statements. Forward-looking statements are based on management's beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including risks and uncertainties related to market conditions and the ability to consummate the offering and sale of shares, the ability to satisfy the closing conditions to the offering; management's discretion over the use of proceeds of the offering; we will require substantial additional capital investment in the future; our mineral projects are all at the exploration or development stage and are subject to the significant risks and uncertainties associated with mineral exploration and development; we have inferred resources that may never be upgraded to a higher category of resource or reserve; we have a limited operating history on which to base an evaluation of our business and prospects; we depend on our material projects for our future operations; our mineral resource and reserve calculations and economic projections relating to our properties are only estimates; actual capital costs, operating costs, production and economic returns may differ significantly from those we have anticipated; the title to some of the mineral properties may be uncertain or defective; our business is subject to changes in the prices of copper, gold, silver, nickel, cobalt, vanadium and platinum group metals; we have claims and legal proceedings against one of our subsidiaries; our business is subject to significant risk and hazards associated with exploration activities, mine development, construction and future mining operations; we may fail to identify attractive acquisition candidates or joint ventures with strategic partners or be unable to successfully integrate acquired mineral properties or successfully manage joint ventures; our success is dependent in part on our joint venture partners and their compliance with our agreements with them; our business is extensively regulated by the United States and foreign governments as well as local governments; we may be adversely affected by tariff and trade actions; we and the VRB China Joint Venture may not receive the anticipated payments from Red Sun in connection with the VRB China Joint Venture transaction in full or in a timely manner; our subsidiary Cordoba's sale of its interest in the Alacrán project may not be completed; the requirements that we obtain, maintain and renew environmental, construction and mining permits are often a costly and time-consuming process; our non-U.S. operations are subject to additional political, economic and other uncertainties not generally associated with domestic operations; and our operations may be impacted by public health emergencies, pandemics, epidemics, or similar events. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements described in or incorporated by reference in Ivanhoe Electric's preliminary prospectus supplement relating to this offering and accompanying base prospectus that form a part of the registration statement on Form S-3, as amended, filed with the SEC and preliminary MJDS prospectus supplement relating to this offering and accompanying final base MJDS prospectus filed with Canadian securities commissions. Ivanhoe Electric expressly disclaims any obligation or undertaking to update the forward-looking statements contained in this press release to reflect any change in its expectations or any change in events, conditions, or circumstances on which such statements are based unless required to do so by applicable law. No assurance can be given that such future results will be achieved. Forward-looking statements speak only as of the date of this press release. We caution you not to place undue reliance on these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271401

ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today the pricing of the previously announced secondary offering by certain selling stockholders affiliated with J.H. Whitney Equity Partners VII, LLC (the “Selling Stockholders”) of 10,000,000 shares of its common stock at a public offering price of $9.00 per share (the “Offering”). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of the Company’s common stock. The Selling Stockholders will receive all of the net proceeds from the Offering. The Company is not offering any shares of its common stock in the Offering and will not receive any of the proceeds from the sale of the shares offered by the Selling Stockholders. The Offering is expected to settle on October 23, 2025, subject to customary closing conditions.

Jefferies and J.P. Morgan are acting as joint lead book-running managers for the Offering. Barclays and RBC Capital Markets are acting as book-running managers for the Offering. BMO Capital Markets, BofA Securities, Truist Securities, Deutsche Bank Securities and PNC Capital Markets LLC are acting as bookrunners for the Offering.

A shelf registration statement on Form S-3 (including a prospectus) relating to these securities has been filed with and declared effective by the Securities and Exchange Commission (the “SEC”). Before you invest, you should read the prospectus in that registration statement, including the documents incorporated by reference therein, the accompanying prospectus supplement and other documents the Company has filed or will file with the SEC for more complete information about the Company and this Offering. You may get these documents, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus supplement and the accompanying prospectus may also be obtained, when available, by contacting Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at 877-821-7388 or by email at [email protected]; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by email: [email protected] and [email protected].

This press release does not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Aveanna Healthcare

Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in this press release regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking statements. Forward-looking statements generally can be identified by the use of terminology such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “should,” “would,” “predict,” “project,” “potential,” “continue,” “could,” “design,” “guidance,” or the negatives of these terms or variations of them or similar expressions. These statements are based on certain assumptions that we have made in light of our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, the risks and uncertainties set forth under the heading “Risk Factors” in Aveanna’s Annual Report on Form 10-K for its 2024 fiscal year filed with the SEC on March 13, 2025, which is available at www.sec.gov. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may prove to be incorrect or imprecise. Accordingly, forward-looking statements included in this press release do not purport to be predictions of future events or circumstances, and actual results may differ materially from those expressed by forward-looking statements. All forward-looking statements speak only as of the date made, and Aveanna undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Intuitive Surgical, Inc. (NASDAQ:ISRG) Q3 2025 Earnings Call October 21, 2025 4:30 PM EDT

Company Participants

Dan Connally
David Rosa - CEO & Director
Jamie Samath - CFO, Head of Business Technology & Enterprise Technology Leader

Conference Call Participants

Robert Marcus - JPMorgan Chase & Co, Research Division
Travis Steed - BofA Securities, Research Division
Larry Biegelsen - Wells Fargo Securities, LLC, Research Division
Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division
Patrick Wood - Morgan Stanley, Research Division
David Roman - Goldman Sachs Group, Inc., Research Division
Adam Maeder - Piper Sandler & Co., Research Division

Presentation

Operator

Thank you for standing by, and welcome to the Intuitive Third Quarter 2025 Earnings Release. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Dan Connally, Head of Investor Relations at Intuitive. Please go ahead, sir.

Dan Connally

Good afternoon, and welcome to Intuitive's Third Quarter Earnings Conference Call. Joining me today are Dave Rosa, our CEO; and Jamie Samath, our CFO.

Before we begin, I would like to remind you that comments on today's call may contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in our Securities and Exchange Commission filings, including our most recent 10-K filed on January 31, 2025, and Form 10-Q filed on July 23, 2025.

Our SEC filings can be found through our website at intuitive.com or at the SEC's website. Investors are cautioned not to place undue reliance on such forward-looking statements. Please note that this conference call will be available for audio replay on our website in the Events section under our Investor Relations page. We have posted today's press release and supplementary financial data tables to our website.

Recommended For You

SAN FRANCISCO--(BUSINESS WIRE)--Unity (NYSE: U), the leading platform to create and grow games and interactive experiences, today announced the general availability of Android XR support in Unity 6 — making it easy for developers to reach new audiences and platforms with their games and apps. “By collaborating closely with Google and Samsung, we integrated Android XR tools into Unity 6 early and verified them with developers in real production environments ahead of the launch,” said Alex Blum,.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of GIS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.